Voxelotor for the treatment of sickle cell disease in pediatric patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Voxelotor for the treatment of sickle cell disease in pediatric patients

Published:2022-06-03 Issue:6 Volume:15 Page:485-492
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Brown Clark¹,Tonda Margaret²,Abboud Miguel R.³

Affiliation:

1. Department of Pediatrics, Emory School of Medicine, Aflac Cancer and Blood Disorder Center of Children’s Healthcare of Atlanta, Atlanta, GA, USA

2. Global Blood Therapeutics, South San Francisco, CA, USA

3. Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon

Funder

paper was developed with assistance from a professional medical writer

Global Blood Therapeutics Inc

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2082408

Reference63 articles.

1. Sickle cell disease

2. Sickle cell disease

3. Intravascular hemolysis and the pathophysiology of sickle cell disease

4. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates

5. Time to Invest in Sickle Cell Anemia as a Global Health Priority

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voxelotor (GBT440) in pediatric sickle cell disease: A review;Pediatric Hematology Oncology Journal;2024-12

2. Disease-Modifying Therapies for Sickle Cell Disease—An Overview;Pediatric Annals;2024-02

3. Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor;Rapid Communications in Mass Spectrometry;2023-11-28

4. The evolving treatment landscape for children with sickle cell disease;The Lancet Child & Adolescent Health;2023-11

5. Signaling mechanisms in red blood cells: A view through the protein phosphorylation and deformability;Journal of Cellular Physiology;2023-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3